Moreover, the time functional link between the regulation of AQP and leptin-dependent changes in lipid flux at the clinical level require the exact characterization of NAFLD and more advanced liver damage stages in patients with respect to weight changes and diet. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.